What is Zepbound?
Zepbound is a newly FDA-approved weight loss medication that contains Tirzepatide, the same active ingredient as Mounjaro. It is a dual GLP-1 and GIP receptor agonist, meaning it enhances both appetite suppression and metabolic regulation for more effective weight loss.
How Does Zepbound Work?
- GLP-1 action: Slows digestion, reduces appetite, and stabilizes blood sugar.
- GIP action: Enhances fat metabolism, helping the body burn fat more efficiently.
Who is Zepbound For?
- Adults with a BMI of 30+ (Obese category)
- Adults with a BMI of 27+ with weight-related conditions (hypertension, diabetes, etc.)
- Those who have struggled with traditional weight loss methods and need additional medical support.
Key Benefits of Zepbound
✔ Faster weight loss than other GLP-1 medications
✔ Targets two hormone pathways instead of one, increasing fat-burning efficiency
✔ Helps with blood sugar control and insulin resistance
Side Effects of Zepbound
- Nausea, vomiting, and diarrhea (common in the first few weeks)
- Low blood sugar if combined with other diabetes medications
- Risk of pancreatitis and gallbladder disease
How is Zepbound Taken?
- Injected once weekly, similar to Wegovy and Mounjaro
- Dose gradually increased to minimize side effects
Who Should Avoid Zepbound?
- Individuals with a history of medullary thyroid cancer
- Pregnant or breastfeeding women
- People with severe gastrointestinal conditions
